Zobrazeno 1 - 10 of 11 pro vyhledávání: '"Brigitte Bosman"'
1
Relationship between mean volume voided and incontinence in children with overactive bladder treated with solifenacin: post hoc analysis of a phase 3 randomised clinical trial
Autor: Brigitte Bosman, Marja Agema, Robert Snijder, Otto Stroosma
Publikováno v: European Journal of Pediatrics
This post hoc Poisson regression analysis investigated the relationship between mean volume voided and incontinence episodes/24 h after fixed frequency adjustment in children with overactive bladder from the LION study, a phase 3, double-blind, rando
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fe2a8be52ddfeb6edb4c0218288c0b1
https://doi.org/10.1007/s00431-020-03635-2
Zobrazit plný text záznamu
2
The pharmacokinetics, safety, and tolerability of mirabegron in children and adolescents with neurogenic detrusor overactivity or idiopathic overactive bladder and development of a population pharmacokinetic model-based pediatric dose estimation
Autor: Camilla Tøndel, Paul Passier, Otto Stroosma, Malgorzata Baka-Ostrowska, Søren Rittig, Brigitte Bosman, Birgitta Kjaeer, Stacey Tannenbaum, Johan Vande Walle
Publikováno v: Rittig, S, Baka-Ostrowska, M, Tøndel, C, Walle, J V, Kjaeer, B, Passier, P, Bosman, B, Stroosma, O & Tannenbaum, S 2020, ' The pharmacokinetics, safety, and tolerability of mirabegron in children and adolescents with neurogenic detrusor overactivity or idiopathic overactive bladder and development of a population pharmacokinetic model-based pediatric dose estimation ', Journal of Pediatric Urology, vol. 16, no. 1, pp. 31.e1-31.e10 . https://doi.org/10.1016/j.jpurol.2019.10.009
Journal of Pediatric Urology
Introduction: Mirabegron, a selective β3-adrenoreceptor agonist, is a well-established alternative to antimuscarinics in adults with overactive bladder (OAB) symptoms and is under development for use in pediatric patients. Understanding drug pharmac
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::936a5f263f3784a0d3d6b45374b049de
https://pure.au.dk/portal/da/publications/the-pharmacokinetics-safety-and-tolerability-of-mirabegron-in-children-and-adolescents-with-neurogenic-detrusor-overactivity-or-idiopathic-overactive-bladder-and-development-of-a-population-pharmacokinetic-modelbased-pediatric-dose-estimation(ef3ee9a0-9ef8-4f65-bbad-09ad22a6d4bc).html
Zobrazit plný text záznamu
3
Long-Term Safety and Efficacy of Solifenacin in Children and Adolescents with Overactive Bladder
Autor: Ellen Dahler, Robin Besuyen, Søren Rittig, Brigitte Bosman, Robert Snijder, Stéphane Bolduc, Donald Newgreen, Adriana Hollestein-Havelaar, Will Sawyer
Publikováno v: Newgreen, D, Bosman, B, Hollestein-Havelaar, A, Dahler, E, Besuyen, R, Snijder, R, Sawyer, W, Rittig, S & Bolduc, S 2017, ' Long-Term Safety and Efficacy of Solifenacin in Children and Adolescents with Overactive Bladder ', Journal of Urology, vol. 198, no. 4, pp. 928-936 . https://doi.org/10.1016/j.juro.2017.05.038
We evaluated the long-term safety and efficacy of once daily oral solifenacin suspension in children (5 to less than 12 years old) and adolescents (12 to less than 18 years old) with overactive bladder.We conducted a 40-week, open label extension of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1bbf364430c4d83082372787285829c
https://doi.org/10.1016/j.juro.2017.05.038
Zobrazit plný text záznamu
4
Long-term efficacy and safety of solifenacin in pediatric patients aged 6 months to 18 years with neurogenic detrusor overactivity: results from two phase 3 prospective open-label studies
Autor: Otto Stroosma, Johan Vande Walle, David T Bolong, Piet Hoebeke, Ellen Dahler, Frank Verheggen, Israel Franco, Brigitte Bosman, Leon N. Davies, Malgorzata Baka-Ostrowska, Robert Snijder, Donald Newgreen
Publikováno v: Journal of Pediatric Urology. 16:180.e1-180.e8
Introduction The standard recommended treatment for neurogenic detrusor overactivity (NDO) is clean intermittent catheterization combined with an antimuscarinic agent. However, the adverse systemic side-effects of oxybutynin, the most widely used age
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a79897b5213343a7d2242822501680b
https://doi.org/10.1016/j.jpurol.2019.12.012
Zobrazit plný text záznamu
5
A phase II dose-ranging study of mirabegron in patients with overactive bladder
Autor: Chapple, Christopher R., Vladimir, Dvorak, Pjotr, Radziszewski, Philip Van Kerrebroeck, Jean Jacques Wyndaele, Brigitte, Bosman, Peter, Boerrigter, Ted, Drogendijk, Arwin, Ridder, Ingrid Van Der Putten Slob, Osamu, Yamaguchi, Carbone, Antonio
Publikováno v: International urogynecology journal
International Urogynecology Journal, 24(9), 1447-1458. Springer-Verlag London Ltd.
International Urogynecology Journal
Mirabegron is a potent and selective beta(3)-adrenoceptor agonist that may represent an alternative treatment option in place of antimuscarinics for patients with overactive bladder. Patients completed a single-blinded, 2-week placebo run-in period f
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12a4faceb17aa81a3f005dfb77a72fc9
https://hdl.handle.net/10067/1107320151162165141
Zobrazit plný text záznamu
8
A Quantitative Method for Measuring Antipsoriatic Activity of Drugs by the Mouse Tail Test
Autor: Brigitte Bosman, Volker Hess, Elmar Friderichs, Theo Matthiesen
Publikováno v: Skin Pharmacology and Physiology. 5:41-48
Topical treatment of the mouse tail with antipsoriatic drugs enhances orthokeratotic cell differentiation in the epidermal scales. We developed a new evaluation system for this test which allows quantification of drug efficacy. Drugs were applied top
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5efc03841e9cd965967c4787d8e1acf3
https://doi.org/10.1159/000211016
Zobrazit plný text záznamu
9
Testing of lipoxygenase inhibitors, cyclooxygenase inhibitors, drugs with immunomodulating properties and some reference antipsoriatic drugs in the modified mouse tail test, an animal model of psoriasis
Autor: Brigitte Bosman
Publikováno v: Skin pharmacology : the official journal of the Skin Pharmacology Society. 7(6)
Topical administration of lipoxygenase and cyclooxygenase inhibitors, antipsoriatic drugs and some immunomodulating drugs on adult mouse tail scales showed variable induction of of orthokeratosis. Dithranol and retinoic acid showed ED50 concentration
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1be3b6afdb43530481b0adf0ba090498
https://pubmed.ncbi.nlm.nih.gov/7946375
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje